Resistance of Beta 2 Microglobulin Null Mice to Sepsis
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
批准号:
6766014
负责人:
EDWARD R SHERWOOD
金额:
$26.43万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30
关键词:
CD1 moleculeCD95 moleculeacid base balanceanimal mortalitycardiovascular functioncell mediated cytotoxicitycell population studycytokinecytolysinscytolysiscytotoxic T lymphocytedisease /disorder modelendopeptidasesflow cytometrygenetic susceptibilitygenetically modified animalsimmunogeneticsinflammationinjurylaboratory mousemajor histocompatibility complexnatural killer cellspathologic processperitonitispore forming proteinseptic shocksepticemia
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Beta2 microglobulin knockout mice are deficient in CD8+ T cells and natural killer T cells. Compared to wild type mice, beta2 microglobulin knockout mice exhibit improved survival during sepsis caused by cecal ligation and puncture (CLP). Further depletion of natural killer cells by injection of anti-asialoGM1 confers near complete resistance to CLP-induced mortality. The mechanisms underlying these observations are unknown. However, two potential mechanisms have high probability. Firstly, CD8+ T, natural killer T and natural killer cells can impact innate immune responses by amplifying production of pro-inflammatory cytokines and chemokines. These cell populations can also cause direct cellular injury during inflammation. Therefore, it is hypothesized that CD8+ T, natural killer T and natural killer cells facilitate or directly mediate sepsis-induced mortality by amplifying the pro-inflammatory response and/or causing direct cellular injury. Secondly, beta2 microgiobulin comprises the beta chain of the class I major histocompatibility complex and the non-classical antigen-presenting molecule CD1. Both of these molecules are important for presentation of self and foreign antigens, respectively, but their roles in regulating inflammatory responses during sepsis are unknown. It is further hypothesized that the class I major histocompatibility complex, CD1 and/or unrecognized beta2 microglobulin-associated molecules play a role in modulating the immune response during sepsis. This research project is designed to test these hypotheses. The following specific aims are proposed: Aim 1: To determine the specific contributions of CD8+ T, natural killer T and natural killer cells, the class I major histocompatibility complex and CD1 to the pathogenesis of lethal intra-abdominal sepsis. Mortality, bacterial counts, organ injury, cardiovascular function and acid-base balance will be measured following CLP in control mice and mice that are deficient in these cell populations and antigen-presenting molecules. Specific Aim 2: To determine the functional roles of CD8+ T, natural killer T and natural killer cells, the class I major histocompatibility complex and CD1 in regulating the pro-inflammatory response during lethal intra-abdominal sepsis. Intra-abdominal and systemic cytokine and chemokine production will be measured following CLP in control mice and mice that are deficient in CD8+ T, natural killer T and natural killer cells, the class I major histocompatibility complex and CD1. Specific Aim 3: To determine the role of cytolytic mechanisms in the pathogenesis of lethal intra-abdominal sepsis. We will evaluate expression of perforin, granzymes, Fas and FasL in control mice and mice that are deficient in CD8+ T, natural killer T and natural killer cells after CLP. The functional roles of the perforin/granzyme and Fas-FasL pathways will be determined by assessing survival, cardiovascular function, organ injury and acid-base balance in perforin-deficient and FasL-deficient mice. These studies are designed to define new mechanisms that are important in the pathogenesis of septic shock with the ultimate goal of developing new treatments for this lethal disease process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage mitochodrial reprogramming and innate immune memory
-
批准号:10550138
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Macrophage mitochodrial reprogramming and innate immune memory
-
批准号:10333362
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10296894
-
项目类别:
-
资助金额:$55.35万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10461115
-
项目类别:
-
资助金额:$52.84万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Equipment supplement to "Training Innate Immunity: A new approach to the treatment of sepsis"
-
批准号:10794766
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Equipment Supplement request for a BD LSR Fortessa Flow Cytometer
-
批准号:9275190
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Training Innate Immunity: A new approach to the treatment of Sepsis
-
批准号:10669060
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2016
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7256520
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7811704
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8578744
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8292209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8509831
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:9091565
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8112517
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7086177
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8692836
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6911533
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:6681426
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:8908015
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位:
Resistance of Beta 2 Microglobulin Null Mice to Sepsis
-
批准号:7786482
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:EDWARD R SHERWOOD
-
依托单位: